Dusseldorf Excess pounds can now simply be squirted away: the hype surrounding the drugs Ozempic and Wegovy is huge – especially since it has been known that the active ingredient semaglutide is not only suitable for treating diabetes, but also for weight loss.
Many celebrities are said to have already used the weight loss injection – including some Hollywood stars, Kim Kardashian and even Tesla boss Elon Musk. The rush for the preparations was so great recently that there were delivery bottlenecks. This is bad for those who really need the drugs: diabetics.
But the weight loss injection not only enchants Hollywood stars and thousands of people who inject themselves with the active ingredient in videos on social media platforms. It also drives the share price of the pharmaceutical supplier Gerresheimer from Düsseldorf, which invited to the general meeting on Wednesday. Bert Fröndhoff from the Handelsblatt company department explains in the podcast why the hype is also making the shareholders of the MDax group happy.
In addition, Handelsblatt reporter Jürgen Klöckner talks about a new study by the consulting firm Boston Consulting Group, which sheds light on the opportunities and risks of artificial intelligence in the world of work.
More: How Gerresheimer benefits from the fight against obesity.
We have an exclusive subscription offer for you as a Handelsblatt Today listener: Test Handelsblatt Premium for four weeks for €1 and always stay informed about what’s moving the financial markets. More information is available here.
If you have any comments, questions, criticism or praise for this episode, please email us at: [email protected]
We can now be reached on WhatsApp, Signal and Telegram via the following number: 01523 – 80 99 427